7 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Merck's Keytruda Gets FDA's Priority Review for Solid Tumors http://www.zacks.com/stock/news/861111/mercks-keytruda-gets-fdas-priority-review-for-solid-tumors?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-861111 Apr 08, 2020 - Merck's (MRK) sBLA seeking approval of Keytruda for advanced solid tumors, based on biomarker, regardless of tumor type, gets FDA's priority review.
Biotech Stock Roundup: AMGN & INCY Focus on Coronavirus Treatments, & More http://www.zacks.com/stock/news/860777/biotech-stock-roundup-amgn-incy-focus-on-coronavirus-treatments-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-860777 Apr 08, 2020 - The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545 Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Regeneron-Sanofi's Dupixent Data Positive in Atopic Dermatitis http://www.zacks.com/stock/news/857351/regeneron-sanofis-dupixent-data-positive-in-atopic-dermatitis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-857351 Apr 06, 2020 - Regeneron (REGN) and Sanofi announce positive detailed data on Dupixent in children aged 6-11 years with uncontrolled severe atopic dermatitis.
Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection http://www.zacks.com/stock/news/852806/incyte-to-evaluate-lead-drug-jakafi-for-covid-19-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-852806 Apr 03, 2020 - Incyte (INCY) plans to work with the FDA for evaluating Jakafi in patients with COVID-19-associated cytokine storm.
Powerful Proof Anyone Can Invest for an Early Retirement - April 01, 2020 http://www.zacks.com/stock/news/848812/powerful-proof-anyone-can-invest-for-an-early-retirement-april-01-2020?cid=CS-ZC-FT-retirement_ideas|secrets_to_an_early_retirement-848812 Apr 01, 2020 - Achieving the financial freedom to retire early is a dream for most, but making that dream a reality isn't as tricky as it sounds. If you are willing to make some serious lifestyle changes and sacrifices, it can be possible.
4 Reasons Biotech Stocks Are a Buy Right Now https://www.fool.com/investing/2020/03/25/4-reasons-biotech-stocks-are-a-buy-right-now.aspx?source=iedfolrf0000001 Mar 25, 2020 - Biotech companies have outperformed the general market -- and there are plenty of reasons to remain optimistic.

Pages: 1

Page 1